tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

GTBP Stock Latest News

GT Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for GTB-3650, an NK Cell Engager for Treatment of CD33+ Leukemia
Press ReleasesGT Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for GTB-3650, an NK Cell Engager for Treatment of CD33+ Leukemia
25d ago
GTBP
GT Biopharma announces FDA clearance of IND application for GTB-3650
PremiumThe Fly
GT Biopharma announces FDA clearance of IND application for GTB-3650
25d ago
GTBP
GT Biopharma files to sell 740,000 shares of common stock for holders
PremiumThe Fly
GT Biopharma files to sell 740,000 shares of common stock for holders
1M ago
GTBP
GT Biopharma Announces CFO Transition and New Financial Leadership
PremiumCompany Announcements
GT Biopharma Announces CFO Transition and New Financial Leadership
1M ago
8K
GTBP
GT Biopharma trading resumes
PremiumThe Fly
GT Biopharma trading resumes
2M ago
GTBP
GT Biopharma trading halted, volatility trading pause
PremiumThe FlyGT Biopharma trading halted, volatility trading pause
2M ago
GTBP
GT Biopharma, Inc. Announces $3.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
PremiumPress Releases
GT Biopharma, Inc. Announces $3.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
2M ago
GTBP
GT Biopharma to sell 740,000 shares at $4.35 in registered direct offering
PremiumThe Fly
GT Biopharma to sell 740,000 shares at $4.35 in registered direct offering
2M ago
GTBP
GT Biopharma Reports Fourth Quarter and Full-Year 2023 Financial Results
PremiumPress Releases
GT Biopharma Reports Fourth Quarter and Full-Year 2023 Financial Results
4M ago
GTBP
GT Biopharma trading halted, news pending
PremiumThe Fly
GT Biopharma trading halted, news pending
6M ago
GTBP
GT Biopharma Announces Reverse Stock Split Update
PremiumCompany Announcements
GT Biopharma Announces Reverse Stock Split Update
6M ago
8K
GTBP
GT Biopharma Announces Corporate Governance and Fiscal Year Changes
PremiumCompany Announcements
GT Biopharma Announces Corporate Governance and Fiscal Year Changes
6M ago
8K
GTBP
GT Biopharma Announces 1-for-30 Reverse Stock Split
PremiumCompany AnnouncementsGT Biopharma Announces 1-for-30 Reverse Stock Split
6M ago
8K
GTBP
GT Biopharma, Inc. Announces 1-for-30 Reverse Stock Split
PremiumPress Releases
GT Biopharma, Inc. Announces 1-for-30 Reverse Stock Split
6M ago
GTBP
GT Biopharma announces 1-for-30 reverse stock split
PremiumThe Fly
GT Biopharma announces 1-for-30 reverse stock split
6M ago
GTBP
Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend GT Biopharma Stockholders Vote “FOR” All Proposed Items at the Upcoming Special Meeting of Stockholders
PremiumPress Releases
Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend GT Biopharma Stockholders Vote “FOR” All Proposed Items at the Upcoming Special Meeting of Stockholders
8M ago
GTBP
GT Biopharma: ISS, Glass Lewis recommend shareholders vote for proposed items
PremiumThe Fly
GT Biopharma: ISS, Glass Lewis recommend shareholders vote for proposed items
8M ago
GTBP
GT Biopharma Announces IND Submission for GTB-3650 for Treatment of CD33+ Leukemia
PremiumPress Releases
GT Biopharma Announces IND Submission for GTB-3650 for Treatment of CD33+ Leukemia
8M ago
GTBP
GT Biopharma announces IND submission for GTB-3650
PremiumThe Fly
GT Biopharma announces IND submission for GTB-3650
8M ago
GTBP
GT Biopharma Presented Positive Preclinical Data for GTB-5550, a Novel TriKE® Molecule for Targeted Prostate Cancer Treatment During the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting
PremiumPress ReleasesGT Biopharma Presented Positive Preclinical Data for GTB-5550, a Novel TriKE® Molecule for Targeted Prostate Cancer Treatment During the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting
9M ago
GTBP
GT Biopharma presents preclinical data for GTB-5550 for targeted prostate cancer
PremiumThe Fly
GT Biopharma presents preclinical data for GTB-5550 for targeted prostate cancer
9M ago
GTBP
GT Biopharma sees cash runway into 2H24
PremiumThe Fly
GT Biopharma sees cash runway into 2H24
9M ago
GTBP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >